# Four-repository release-gate verification — 2026-11-07 15:01 IST

## Fresh GitHub open-item search
- Corporate: 2 PRs (#112, #118), 9 issues (#54, #55, #86, #90, #106, #107, #108, #109, #110).
- Portfolio: 0 PRs, 1 issue (#43, qualified editorial approval).
- Innovation Technology: 1 PR (#3 temporary data workflow, never merge without source artifact), 0 issues.
- AK Online Services: 0 PRs, 0 issues.
Counts are from fresh open searches and do not establish release completion.

## Source verification and concrete changes since earlier audit
- Corporate main anchor: `f51d42f1919aeb371871e6329ba61f87ff9048ca` (GitHub compare base).
- PR #112 branch `feat/nutraxin-publisher-19links-current-main-20261107` now compares **13 ahead, 0 behind** main, five files. Previous 8 ahead / 13 behind and six-file reports are obsolete. This is a source comparison, not CI proof.
- Independently fetched `apps/corporate/data/nutraxin-uk-links.json`: `verifiedOn: 2026-11-07`; broken Vitamin C chewable URL replaced with **null**, and `unavailableProductNotes` explicitly documents HTTP 404. No invented substitute, regulatory approval, inventory or availability. This removes the previously identified broken outbound destination from source, subject to current branch acceptance.
- Independently fetched `apps/corporate/test/nutraxin-publisher-links.test.ts`: verifies 19 catalogue dispositions, exactly one null, 18 unique official HTTPS product URLs, no credentials/search/hash, explicit non-approval scope. Test source reviewed; **not executed locally**.
- Earlier exact commit `6107d89ec35aae20b985a0627e97399d1dcb66d9` had production-readiness success [42347944759](https://github.com/NovapharmHealthacre/novapharm-website/actions/runs/42347944759), CodeQL success [42347944747](https://github.com/NovapharmHealthacre/novapharm-website/actions/runs/42347944747), supply chain success [42347944770](https://github.com/NovapharmHealthacre/novapharm-website/actions/runs/42347944770), visual success [42347944756](https://github.com/NovapharmHealthacre/novapharm-website/actions/runs/42347944756), public browser success [42347944800](https://github.com/NovapharmHealthacre/novapharm-website/actions/runs/42347944800), but unified browser [42347944828](https://github.com/NovapharmHealthacre/novapharm-website/actions/runs/42347944828) was **cancelled**. Those runs do not certify the newer branch.
- PR #118 branch `fix/technology-purpose-heading-contrast-20261107` compares **3 ahead, 0 behind** main, two changed files (CSS and public browser test). Must validate computed large-text contrast >=3:1 and exact-head 390px/1440px Chromium/WebKit before merging.

## Production gates
- Corporate Pages _site build/deploy, HTTPS custom-domain source-to-live parity and rollback still not independently proven for this run. Never equate a main commit or gh-pages branch SHA with a deployed artifact.
- AWS eu-north-1 ECS/RDS/Entra federation, Atlas connectivity, SES production sending and real contact receipt unaccepted. Preserve fail-closed public contact/portal and old Azure recoverability.
- Portfolio issue #43 needs qualified human editorial approval; innovation PR #3 must remain unmerged.
- No DNS, credentials, allowlist, regulated data, provisioning, publishing or merges were changed in this audit.

## Next dependency
Obtain current exact PR head SHAs for #112/#118; inspect their full check conclusions and browser artifacts, especially unified WebKit and WCAG contrast. Merge only after exact-head green, owner release review, publication/rollback mapping. Verify the real Pages origin and custom domain separately.
